- Details
- Written by IVPost
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13 percent of the population with DMD.
- Details
- Written by White House
- Category: Health News
Washington, DC - Vice President Joe Biden announced a series of new steps focused on increasing access to information about clinical trials and improving the efficiency of our clinical research system. These steps include (1) making it easier for participants to find clinical trial opportunities as quickly as possible, (2) incentivizing new ways of designing clinical trials to maximize participation while minimizing burden and risk, and (3) strengthening the transparency of clinical trials and trial results.
- Details
- Written by IVN
- Category: Health News
Irvine, California - The U.S. Food and Drug Administration today permitted marketing of a device that uses a small balloon to treat persistent Eustachian tube dysfunction (ETD), a condition in which pressure, pain or clogged or muffled sensations occur in the ear.
- Details
- Written by American Heart Association
- Category: Health News
Dallas, Texas - Smoking is associated with thicker heart walls and reduction in the heart’s pumping ability, two factors associated with increased risk of heart failure, according to new research in the American Heart Association’s journal Circulation: Cardiovascular Imaging.
- Details
- Written by IVN
- Category: Health News
Sacramento, California - Health leaders are challenging communities statewide to find creative, innovative ways to improve the health of all Californians.
- Details
- Written by Akeem Ranmal
- Category: Health News
Dallas, Texas - Getting recommended levels of exercise weekly may help keep down annual medical costs both for people with and without cardiovascular disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Page 83 of 374
